Church & Dwight Co. (0R13)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 104.26 |
|---|---|
| 52-week range | 80.28 – 107.18 |
| Return, 1 month / 3 months | +8.5% / +7.3% |
| Return, 1 year / 3 years | +19.8% / +15.3% |
| Trend | Uptrend |
| RSI (14) | 76 |
| Volatility (1 year) | 22.1% |
| Worst drawdown (1 year) | -13.5% |
| Average daily value traded | 0.03M USD |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Church & Dwight Co. makes household and personal care products sold to consumers through grocery, drug and mass-merchandise retailers. Its brands include Arm & Hammer baking soda and laundry detergent, OxiClean stain removers, Trojan condoms and a range of personal care items. The company is based in Ewing, New Jersey, in the United States, and its products reach households in many countries around the world.
On this site Church & Dwight Co. appears as a stock on the London Exchange (UK), code 0R13, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Church & Dwight Co. (0R13) trades on the London Exchange in UK. It last closed at USD 104.26 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 789 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.8% and over the last three months it rose 7.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 74 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.4% | ||
| From 52-week high | -0.1% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.3% | ||
| 6-month return | 11.1% | ||
| 12-month return, skipping the last month | 10.4% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.5% | ||
| Liquidity | 21 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +6.5% |
|---|---|
| 1 month | +8.5% |
| 3 months | +7.3% |
| 6 months | +11.1% |
| 1 year | +19.8% |
| 3 years | +15.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 98.42 / 96.16 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | USD 0.3075 |
| 15 May 2026 | USD 0.3075 |
| 12 Feb 2026 | USD 0.3075 |
| 13 Nov 2025 | USD 0.2950 |
| 14 Aug 2025 | USD 0.2950 |
| 14 May 2025 | USD 0.2950 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.